Silverback Therapeutics (SBTX) PT Lowered to $25 at SVB Leerink

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Silverback Therapeutics (SBTX) PT Lowered to $25 at SVB Leerink

Silverback Therapeutics (SBTX) Reports Preclinical Data for SBT8230

November 12, 2021 8:33 AM EST

Silverback Therapeutics, Inc. (Nasdaq: SBTX), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases, today announced the presentation of preclinical data for SBT8230 at the American Association for the Study of Liver... More